Chromicent

Dear customers and friends of Chromicent, The Chromicent team wishes you a Merry Christmas, a peaceful holiday season and a Happy New Year.

Dear customers and friends of Chromicent, our information letter for autumn 2020 has been released. You will find it in the following for download as… Read More »News from the Chromicent

The Chromicent is now using a BioAccord system from Waters. What is special about it? BioAccord is a Ready to Use LC-MS system that enables… Read More »Take the next step with us

September at Chromicent was all about digitalization. In cooperation with the HTW Berlin, we have subjected Chromicent to a digital checkup as part of the… Read More »Digitization – Key Topic of our Time

The EMA has published a final statement on nitrosamine impurities in medicinal products. The full report can be found *here*. The publication of Chromicent is… Read More »EMA – Statement Nitrosamine

Dear customers and friends of Chromicent, we have good news and would like to share it with you. You will find our detailed information letter… Read More »News from the Chromicent

Chromicent has enhanced its portfolio with size exchange chromatography (SEC). This chromatographic method enables us to separate molecules in solution by size (hydrodynamic volume) and… Read More »New: Size Exclusion Chromatography (SEC)

This conference provides a comprehensive overview of the new ICH Quality Guideline Q14 on Analytical Procedure Development, and the revised Q2 Guideline on Validation of… Read More »ICH Q2/Q14 Analytical Procedure Life Cycle Management

We are pleased to recommend another webinar: Analytical design space modeling in accordance with ICH Q12 and proposed Q14: Using a novel approach for in… Read More »Analytical Design Space Modeling

In the field of pharmaceutical safety, nitrosamines remain a crucial issue. In a webinar entitled “Analysis of nitrosamines in APIs by LC/MS: How to face… Read More »Challenge: Nitrosamines